Report Detail

Service & Software Global Drug Safety and Pharmacovigilance Solution Market Size, Status and Forecast 2020-2026

  • RnM4109269
  • |
  • 29 July, 2020
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Service & Software

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Safety and Pharmacovigilance Solution Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Issue Tracking Solution
    • 1.2.3 Fully Integrated Solution
    • 1.2.4 Adverse Event Reporting Solution
    • 1.2.5 Drug Safety Audits Software
  • 1.3 Market by Application
    • 1.3.1 Global Drug Safety and Pharmacovigilance Solution Market Share by Application: 2020 VS 2026
    • 1.3.2 BPOs
    • 1.3.3 CROs
    • 1.3.4 Pharmaceutical Companies
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug Safety and Pharmacovigilance Solution Market Perspective (2015-2026)
  • 2.2 Global Drug Safety and Pharmacovigilance Solution Growth Trends by Regions
    • 2.2.1 Drug Safety and Pharmacovigilance Solution Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Drug Safety and Pharmacovigilance Solution Historic Market Share by Regions (2015-2020)
    • 2.2.3 Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drug Safety and Pharmacovigilance Solution Players by Market Size
    • 3.1.1 Global Top Drug Safety and Pharmacovigilance Solution Players by Revenue (2015-2020)
    • 3.1.2 Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Players (2015-2020)
  • 3.2 Global Drug Safety and Pharmacovigilance Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Solution Revenue
  • 3.4 Global Drug Safety and Pharmacovigilance Solution Market Concentration Ratio
    • 3.4.1 Global Drug Safety and Pharmacovigilance Solution Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Solution Revenue in 2019
  • 3.5 Key Players Drug Safety and Pharmacovigilance Solution Area Served
  • 3.6 Key Players Drug Safety and Pharmacovigilance Solution Product Solution and Service
  • 3.7 Date of Enter into Drug Safety and Pharmacovigilance Solution Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety and Pharmacovigilance Solution Breakdown Data by Type (2015-2026)

  • 4.1 Global Drug Safety and Pharmacovigilance Solution Historic Market Size by Type (2015-2020)
  • 4.2 Global Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Type (2021-2026)

5 Drug Safety and Pharmacovigilance Solution Breakdown Data by Application (2015-2026)

  • 5.1 Global Drug Safety and Pharmacovigilance Solution Historic Market Size by Application (2015-2020)
  • 5.2 Global Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
  • 6.2 North America Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
  • 6.3 North America Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
  • 6.4 North America Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
  • 7.2 Europe Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
  • 7.3 Europe Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
  • 7.4 Europe Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
  • 8.2 China Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
  • 8.3 China Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
  • 8.4 China Drug Safety and Pharmacovigilance Solution Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
  • 9.2 Japan Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
  • 9.3 Japan Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
  • 9.4 Japan Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
  • 10.2 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Ennov
    • 11.1.1 Ennov Company Details
    • 11.1.2 Ennov Business Overview
    • 11.1.3 Ennov Drug Safety and Pharmacovigilance Solution Introduction
    • 11.1.4 Ennov Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020))
    • 11.1.5 Ennov Recent Development
  • 11.2 AB-Cube
    • 11.2.1 AB-Cube Company Details
    • 11.2.2 AB-Cube Business Overview
    • 11.2.3 AB-Cube Drug Safety and Pharmacovigilance Solution Introduction
    • 11.2.4 AB-Cube Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.2.5 AB-Cube Recent Development
  • 11.3 Oracle
    • 11.3.1 Oracle Company Details
    • 11.3.2 Oracle Business Overview
    • 11.3.3 Oracle Drug Safety and Pharmacovigilance Solution Introduction
    • 11.3.4 Oracle Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.3.5 Oracle Recent Development
  • 11.4 Extedo
    • 11.4.1 Extedo Company Details
    • 11.4.2 Extedo Business Overview
    • 11.4.3 Extedo Drug Safety and Pharmacovigilance Solution Introduction
    • 11.4.4 Extedo Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.4.5 Extedo Recent Development
  • 11.5 ArisGlobal
    • 11.5.1 ArisGlobal Company Details
    • 11.5.2 ArisGlobal Business Overview
    • 11.5.3 ArisGlobal Drug Safety and Pharmacovigilance Solution Introduction
    • 11.5.4 ArisGlobal Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.5.5 ArisGlobal Recent Development
  • 11.6 Sarjen Systems
    • 11.6.1 Sarjen Systems Company Details
    • 11.6.2 Sarjen Systems Business Overview
    • 11.6.3 Sarjen Systems Drug Safety and Pharmacovigilance Solution Introduction
    • 11.6.4 Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.6.5 Sarjen Systems Recent Development
  • 11.7 RxLogix
    • 11.7.1 RxLogix Company Details
    • 11.7.2 RxLogix Business Overview
    • 11.7.3 RxLogix Drug Safety and Pharmacovigilance Solution Introduction
    • 11.7.4 RxLogix Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.7.5 RxLogix Recent Development
  • 11.8 Sparta Systems
    • 11.8.1 Sparta Systems Company Details
    • 11.8.2 Sparta Systems Business Overview
    • 11.8.3 Sparta Systems Drug Safety and Pharmacovigilance Solution Introduction
    • 11.8.4 Sparta Systems Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.8.5 Sparta Systems Recent Development
  • 11.9 United BioSource LLC (UBC)
    • 11.9.1 United BioSource LLC (UBC) Company Details
    • 11.9.2 United BioSource LLC (UBC) Business Overview
    • 11.9.3 United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Introduction
    • 11.9.4 United BioSource LLC (UBC) Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.9.5 United BioSource LLC (UBC) Recent Development
  • 11.10 TARA (MedGenesis)
    • 11.10.1 TARA (MedGenesis) Company Details
    • 11.10.2 TARA (MedGenesis) Business Overview
    • 11.10.3 TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Introduction
    • 11.10.4 TARA (MedGenesis) Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 11.10.5 TARA (MedGenesis) Recent Development
  • 11.11 BaseCon
    • 10.11.1 BaseCon Company Details
    • 10.11.2 BaseCon Business Overview
    • 10.11.3 BaseCon Drug Safety and Pharmacovigilance Solution Introduction
    • 10.11.4 BaseCon Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 10.11.5 BaseCon Recent Development
  • 11.12 Indegene
    • 10.12.1 Indegene Company Details
    • 10.12.2 Indegene Business Overview
    • 10.12.3 Indegene Drug Safety and Pharmacovigilance Solution Introduction
    • 10.12.4 Indegene Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
    • 10.12.5 Indegene Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Drug Safety and Pharmacovigilance Solution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Safety and Pharmacovigilance Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Issue Tracking Solution
    Fully Integrated Solution
    Adverse Event Reporting Solution
    Drug Safety Audits Software

    Market segment by Application, split into
    BPOs
    CROs
    Pharmaceutical Companies
    Others

    Based on regional and country-level analysis, the Drug Safety and Pharmacovigilance Solution market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Drug Safety and Pharmacovigilance Solution market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Ennov
    AB-Cube
    Oracle
    Extedo
    ArisGlobal
    Sarjen Systems
    RxLogix
    Sparta Systems
    United BioSource LLC (UBC)
    TARA (MedGenesis)
    BaseCon


    Summary:
    Get latest Market Research Reports on Drug Safety and Pharmacovigilance Solution. Industry analysis & Market Report on Drug Safety and Pharmacovigilance Solution is a syndicated market report, published as Global Drug Safety and Pharmacovigilance Solution Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Drug Safety and Pharmacovigilance Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,981.53
    4,472.30
    5,963.06
    3,300.96
    4,951.43
    6,601.91
    412,382.10
    618,573.15
    824,764.20
    292,433.70
    438,650.55
    584,867.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report